The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 24, 2020

Filed:

Nov. 30, 2017
Applicant:

The Hospital for Sick Children, Toronto, CA;

Inventors:

Roman A. Melnyk, Oakville, CA;

Anick Auger, Montreal, CA;

Greg Beilhartz, Toronto, CA;

Berge Minassian, Toronto, CA;

Seiji Sugiman-Marangos, Toronto, CA;

Assignee:
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/02 (2006.01); C07H 21/04 (2006.01); C12N 15/62 (2006.01); A61K 35/74 (2015.01); C07K 14/34 (2006.01); C07K 14/28 (2006.01); C07K 14/33 (2006.01); C07K 14/47 (2006.01); C07K 14/475 (2006.01); C12N 9/10 (2006.01); C12N 9/22 (2006.01); C12N 9/28 (2006.01); C12N 9/52 (2006.01); A61K 38/45 (2006.01); A61K 38/48 (2006.01); A61K 47/68 (2017.01); A61K 47/42 (2017.01); C07K 7/08 (2006.01); C07K 14/00 (2006.01); C07K 16/12 (2006.01); C12N 11/06 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/62 (2013.01); A61K 35/74 (2013.01); A61K 38/45 (2013.01); A61K 38/48 (2013.01); A61K 47/42 (2013.01); A61K 47/6829 (2017.08); C07K 7/08 (2013.01); C07K 14/001 (2013.01); C07K 14/28 (2013.01); C07K 14/33 (2013.01); C07K 14/34 (2013.01); C07K 14/4703 (2013.01); C07K 14/475 (2013.01); C07K 16/1282 (2013.01); C12N 9/1051 (2013.01); C12N 9/1077 (2013.01); C12N 9/22 (2013.01); C12N 9/2417 (2013.01); C12N 9/52 (2013.01); C12N 11/06 (2013.01); A61K 38/00 (2013.01); C07K 2319/10 (2013.01); C07K 2319/21 (2013.01); C07K 2319/22 (2013.01); C07K 2319/35 (2013.01); C07K 2319/41 (2013.01); C07K 2319/50 (2013.01); C07K 2319/55 (2013.01); C07K 2319/60 (2013.01); C07K 2319/75 (2013.01); C12N 2310/20 (2017.05);
Abstract

There is a need for delivery platforms with robust capacity that offer the possibility to deliver diverse protein-based therapeutics into specific cells. Described herein is a platform for delivering cargo polypeptides into cells, which is based on a recombinant molecule comprising: a cargo polypeptide, a diphtheria toxin enzymatic fragment (DTA), and a diphtheria toxin translocation fragment (DTB). The platform has been employed to deliver diverse cargo into cells, including those having low or high molecular weights. A hyper-stable cargo polypeptide has been delivered, as well as proteins of therapeutic significance (e.g, MecP2, SMN, FMRP, PNP, alpha-amylase, and RRSP). The platform is also useful for delivering genome-modifying proteins, such as the CRISPR protein, Cas9. Associated nucleic acids, pharmaceutical compositions, methods, uses, and kits are also described, including those of therapeutic significance aimed at treating diseases or disorders caused by enzyme or protein deficiency.


Find Patent Forward Citations

Loading…